WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH NEWS

Warptech News aggrega le notizie più rilevanti da oltre 150 fonti internazionali, con classificazione AI e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Cerca
  • Il tuo account

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Fonte

pharmaceutical-technology.com

8articoli totali nell'archivio

pharmaceutical-technology.com

Biopharma industry endorses Pazdur for FDA commissioner role - Pharmaceutical…

Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.

pharmaceutical-technology.com·2 g fa
pharmaceutical-technology.com

Kyowa Kirin secures FDA approval for Crysvita dosing update

Kyowa Kirin has received approval from the FDA for a dosing update to the Crysvita prescribing information, introducing a new…

pharmaceutical-technology.com·2 g fa
pharmaceutical-technology.com

UK health secretary Wes Streeting resigns - Pharmaceutical Technology

Streeting’s resignation comes in the wake of the Labour party’s poor performance in the local elections, held on 7 May.

pharmaceutical-technology.com·3 g fa
pharmaceutical-technology.com
health

Regulatory round-up: A month of key FDA approvals for cancer drugs -…

Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications.

pharmaceutical-technology.com·3 g fa
pharmaceutical-technology.com
health

Imfinzi set to become first immunotherapy for stomach cancer patients on NHS -…

AstraZeneca’s targeted treatment helps patients live longer, along with preventing cancer recurrence.

pharmaceutical-technology.com·3 g fa
pharmaceutical-technology.com

Pfizer receives EC approval for Hympavzi to treat haemophilia

Pfizer has received EC approval to expand the Hympavzi indication to treat haemophilia A or B with inhibitors in patients aged 12…

pharmaceutical-technology.com·3 g fa
pharmaceutical-technology.com
healthscience

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer -…

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

pharmaceutical-technology.com·6 mesi fa